Imipenem + Cilastatin

Welcome to Dwaey, specifically on Imipenem + Cilastatin page.
This medicine contains important and useful components, as it consists of
Imipenem + Cilastatin is available in the market in concentration.

Generic Name of Imipenem + Cilastatin - Learn More

Imipenem + Cilastatin

Imipenem + Cilastatin Precaution - What You Need to Know

When using Imipenem and Cilastatin, there are several important precautions to consider to ensure safety and minimize the risk of adverse effects:

- Pregnancy and breastfeeding:
- Imipenem is classified as a Category C drug by the FDA, indicating that its use in pregnancy should be considered only when the potential benefits outweigh the risks. Animal studies have shown some risks, but there is limited data on its safety in humans.
- Cilastatin does not have specific concerns for pregnancy, but the combination with imipenem should be approached cautiously.
- Breastfeeding: Imipenem is excreted in breast milk in small amounts. Therefore, breastfeeding mothers should only use imipenem if the benefits outweigh the risks, and should monitor the infant for any adverse reactions.

- Renal function:
- Both imipenem and cilastatin should be used with caution in patients with impaired renal function. Imipenem is primarily eliminated via the kidneys, and dose adjustments are required based on renal function. The renal dose adjustment is essential to avoid toxicity.
- Monitoring renal function is critical, especially in elderly patients or those with pre-existing kidney disease.

- Seizure risk:
- One of the significant precautions when using imipenem is its potential to lower the seizure threshold. This is more common in patients with central nervous system disorders, brain lesions, or renal impairment.
- Caution should be exercised in patients who have a history of seizures, and imipenem should be used at the lowest effective dose in these individuals. If seizures occur, discontinuation or dose adjustment may be necessary.

- Allergy and hypersensitivity reactions:
- Patients with a known allergy to penicillin or cephalosporins should be cautious, as there is a potential for cross-reactivity between beta-lactam antibiotics. Severe allergic reactions (such as anaphylaxis) are rare but possible.

- Gastrointestinal issues:
- Prolonged use of imipenem and cilastatin may alter the normal gut flora, leading to the overgrowth of resistant organisms like Clostridium difficile, which can cause antibiotic-associated colitis. If gastrointestinal symptoms such as diarrhea, abdominal pain, or fever develop, discontinuation of the drug should be considered.

Imipenem + Cilastatin Indication - Uses and Benefits

Imipenem and cilastatin are a combination of antibiotic therapy used to treat a wide range of infections, particularly those caused by gram-positive, gram-negative bacteria, and anaerobes.

- Imipenem is a broad-spectrum carbapenem antibiotic that acts by inhibiting bacterial cell wall synthesis. It is effective against a variety of organisms, including those resistant to other antibiotics. Cilastatin, a renal dehydropeptidase inhibitor, is added to prevent the inactivation of imipenem in the kidneys, allowing it to maintain its therapeutic effect.

- Infections:
- Severe or high-risk infections: Imipenem and cilastatin are used to treat life-threatening infections such as pneumonia, sepsis, endocarditis, intra-abdominal infections, and urinary tract infections caused by susceptible organisms.
- Complicated skin and soft tissue infections: This combination is useful in treating severe skin infections, including diabetic foot infections or wound infections in hospitalized patients.
- Bone and joint infections: For patients with osteomyelitis or septic arthritis, imipenem and cilastatin are effective due to their broad-spectrum action.
- Meningitis: Imipenem can cross the blood-brain barrier, making it effective in treating meningitis, particularly in severe cases caused by susceptible organisms.

- Off-label uses:
- Imipenem and cilastatin are sometimes used off-label for infections that are resistant to other antibiotics, as well as for complex or polymicrobial infections that involve a mixture of bacterial species.
- Pseudomonas aeruginosa infections: This combination is often used in severe infections caused by Pseudomonas aeruginosa, particularly in critically ill patients.

Imipenem + Cilastatin Contraindications - Important Warnings

There are specific situations where imipenem and cilastatin should not be used due to safety concerns:

- Allergy to beta-lactam antibiotics:
- Patients who are allergic to penicillins, cephalosporins, or other beta-lactam antibiotics should avoid using imipenem. This is due to the potential for cross-reactivity among these antibiotics.

- History of seizures:
- Imipenem has been associated with an increased risk of seizures, particularly in patients with a history of seizure disorders or those who have conditions such as brain lesions, CNS infections, or renal dysfunction. Its use is contraindicated in these individuals, or it should be used with extreme caution.

- Severe renal impairment:
- Imipenem is primarily excreted through the kidneys, and its use is contraindicated in patients with severe renal dysfunction without appropriate dose adjustment. In cases of significant renal impairment, a lower dose or extended dosing intervals should be used.

- Pregnancy:
- While imipenem is a Category C drug, it should only be used during pregnancy if the benefit outweighs the risk, as there is limited data regarding its safety during gestation.

Imipenem + Cilastatin Side Effects - What to Expect

Imipenem and cilastatin can cause a range of side effects, though most are relatively mild:

- Common side effects:
- Gastrointestinal issues: These include nausea, vomiting, diarrhea, and abdominal pain. These effects are typically mild and resolve with the discontinuation of the drug.
- Rash: A skin rash may occur in some individuals, often indicating an allergic reaction, which should be monitored.

- Serious side effects:
- Seizures: The most serious side effect associated with imipenem is the risk of seizures, particularly in those with renal impairment or pre-existing neurological disorders. The drug should be discontinued if seizures occur.
- Allergic reactions: Rare but potentially serious reactions include anaphylaxis, angioedema, or hypotension, particularly in patients with a history of beta-lactam allergy.
- Renal toxicity: Imipenem can be nephrotoxic, especially in patients with pre-existing renal dysfunction. Close monitoring of kidney function is required during treatment.

- Long-term effects:
Prolonged use of imipenem and cilastatin may result in the development of antibiotic resistance or superinfections, such as Clostridium difficile-associated diarrhea.

Imipenem + Cilastatin Pregnancy Category ID - Safety Information

3

Imipenem + Cilastatin Mode of Action - How It Works

- Imipenem is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs). This action leads to the weakening of the bacterial cell wall and ultimately bacterial cell death. Imipenem is effective against a wide range of bacteria, including gram-positive and gram-negative organisms.

- Cilastatin is a renal dehydropeptidase inhibitor. It inhibits the enzyme that normally breaks down imipenem in the kidneys, allowing imipenem to remain active and effective at therapeutic concentrations. Cilastatin helps to increase the duration of imipenem's action in the body and prevents nephrotoxicity caused by the accumulation of the drug's metabolites in the kidneys.

- The combination of imipenem and cilastatin extends the antibiotic's spectrum and effectiveness, particularly against multi-drug resistant pathogens. It also helps prevent the renal toxicity typically associated with imipenem monotherapy.

Imipenem + Cilastatin Drug Interactions - What to Avoid

Several drug interactions should be considered when using imipenem and cilastatin:

- Probenecid:
- Probenecid is known to increase blood levels of imipenem by inhibiting its renal tubular secretion. While this can lead to higher imipenem concentrations, this interaction is typically utilized in clinical settings where higher doses or prolonged exposure to the drug is desired. However, this combination requires careful monitoring to avoid toxicity.

- Other nephrotoxic drugs:
- Concomitant use of imipenem and cilastatin with other nephrotoxic drugs (e.g., aminoglycosides, NSAIDs, radiocontrast agents) can increase the risk of renal toxicity. Renal function should be monitored closely when these drugs are used together.

- Valproic acid:
- Imipenem can lower the blood levels of valproic acid, an anticonvulsant, potentially leading to reduced seizure control. This interaction can be clinically significant in patients receiving both medications.

- Anticoagulants:
- There may be a mild anticoagulant effect when imipenem and cilastatin are used with anticoagulant therapy (such as warfarin), increasing the risk of bleeding. Monitoring of clotting parameters is recommended.

- Oral contraceptives:
- While there is no direct interaction with oral contraceptives, as with any antibiotic, imipenem may alter gut flora and potentially reduce the effectiveness of birth control pills. Alternative contraception methods are recommended during antibiotic therapy.

Imipenem + Cilastatin Adult Dose - Recommended Dosage

- The standard dose for imipenem/cilastatin for adults is typically 500 mg to 1 g every 6–8 hours depending on the severity of the infection.
- For serious infections, higher doses of 1 g every 6 hours may be used. The total daily dose should not exceed 4 g.
- Dosing should be adjusted in cases of renal impairment to prevent toxicity, and the maximum dose may be reduced based on creatinine clearance.

Imipenem + Cilastatin Child Dose - Dosage for Children

- The pediatric dose of imipenem/cilastatin depends on the child's weight and the severity of the infection:
- For children aged 3 months and older, the typical dose is 15–25 mg/kg every 6–8 hours, with a maximum dose of 1 g per dose.
- For neonates or those with renal dysfunction, dose adjustments are needed based on the infant's age and renal function. Always consult a pediatrician for dosing recommendations.

Imipenem + Cilastatin Renal Dose - Dosage for Kidney Conditions

- Dose adjustment is required for patients with renal impairment. In cases of creatinine clearance of 20–40 mL/min, the dosing interval may be extended to 12 hours, and for creatinine clearance < 20 mL/min, the dosing interval should be every 24 hours.
- Monitoring of renal function is critical throughout therapy to avoid toxicity, especially in those with existing kidney disease.